BackXintela AB (publ) Overview

Xintela AB (publ) Current Cash

Track Xintela AB (publ)'s current cash ($31M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$30.72M
↑ 191.72% YoYΔ $20.19M vs prior year quarter

Peer trimmed avg / median

Loading

Xintela AB (publ) Current Cash History

Loading

Xintela AB (publ) vs. peers: Current Cash Comparison

Loading

Xintela AB (publ) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Xintela AB (publ) (XINT.ST) FAQ

The latest current cash for XINT.ST is $31M as of June 2026. That compares with $11M in the prior-year period — up 191.7% year over year. Investors often review this figure alongside Xintela AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, XINT.ST's current cash moved from $11M to $31M — a 191.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Xintela AB (publ)'s operating scale or balance-sheet position.

A current cash figure of $31M for XINT.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting XINT.ST's current cash ($31M), review year-over-year change from $11M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Xintela AB (publ)'s current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.

Questions & Answers